Lakefront Biotherapeutics (LKFT) Pension (2014 - 2025)

Lakefront Biotherapeutics (LKFT) has reported Pension for 12 consecutive years, with $2.4 million the latest figure, recorded in Q3 2025.

• Quarterly Pension fell 8.03% year-over-year to $2.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.4 million (down 8.03% YoY) and the FY2024 annual result came in at $2.4 million, down 8.46% from the prior year.
• Pension held at $2.4 million in Q3 2025 per LKFT's latest filing, from $2.4 million in the prior quarter.
• Over the last five years, Pension for LKFT reached as high as $17.1 million in Q2 2021 and fell as low as $2.4 million in Q1 2025.
• A 5-year average of $5.6 million and a median of $2.6 million in 2023 frame the typical range for Pension.
• Annual changes were most pronounced in 2021 — Pension surged 76.61% — and 2023, when it slumped 77.95%.
• Year by year, Pension stood at $13.3 million in 2021, then slumped by 52.65% to $6.3 million in 2022, then tumbled by 58.61% to $2.6 million in 2023, then retreated by 8.46% to $2.4 million in 2024, then advanced by 0.38% to $2.4 million in 2025.
• According to Business Quant data, Pension over the past three periods registered $2.4 million, $2.4 million, and $2.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.